Dupixent and Skin blushing/flushing - a phase IV clinical study of FDA data
Summary:
Skin blushing/flushing is found among people who take Dupixent, especially for people who are female, 20-29 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Dupixent and have Skin blushing/flushing. It is created by eHealthMe based on reports of 125,036 people who have side effects when taking Dupixent from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
125,036 people reported to have side effects when taking Dupixent.
Among them, 272 people (0.22%) have Skin blushing/flushing.
What is Dupixent?
Dupixent has active ingredients of dupilumab. eHealthMe is studying from 125,090 Dupixent users for its effectiveness, alternative drugs and more.
What is Skin blushing/flushing?
Skin blushing/flushing (a sudden reddening of the face, neck) is found to be associated with 3,296 drugs and 2,729 conditions by eHealthMe.
Number of Dupixent and Skin blushing/flushing reports submitted per year:
Time on Dupixent when people have Skin blushing/flushing *:
Gender of people who have Skin blushing/flushing when taking Dupixent*:
Age of people who have Skin blushing/flushing when taking Dupixent *:
Common drugs people take besides Dupixent *:
Common side effects people have besides Skin blushing/flushing *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Dupixent and have Skin blushing/flushing?
Check whether Skin blushing/flushing is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Skin blushing/flushing and when was it recovered:
Expand to all the drugs that have ingredients of dupilumab:
Alternative drugs to, pros and cons of Dupixent:
- Dupixent (125,090 reports)
Common Dupixent side effects:
- Rashes (redness): 14,713 reports
- Itching: 11,478 reports
- Drug ineffective: 7,446 reports
- Dry skin: 4,984 reports
- Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 4,733 reports
- Dry eyes (lack of adequate tears): 3,864 reports
- Joint pain: 3,702 reports
Browse all side effects of Dupixent:
a b c d e f g h i j k l m n o p q r s t u v w x y zSkin blushing/flushing treatments and more:
- Skin blushing/flushing (107,537 reports)
COVID vaccines that are related to Skin blushing/flushing:
- Skin blushing/flushing in Moderna COVID Vaccine
- Skin blushing/flushing in Pfizer BioNTech Covid Vaccine
- Skin blushing/flushing in Johnson and Johnson Covid Vaccine
Common drugs associated with Skin blushing/flushing:
- Niaspan: 18,900 reports
- Tecfidera: 18,304 reports
- Aspirin: 9,341 reports
- Simcor: 5,358 reports
- Lisinopril: 3,993 reports
- Fish oil: 3,195 reports
- Metformin: 3,096 reports
- Prednisone: 3,006 reports
- Lipitor: 2,813 reports
- Benadryl: 2,801 reports
All the drugs that are associated with Skin blushing/flushing:
- Skin blushing/flushing (3,296 drugs)
Common conditions associated with Skin blushing/flushing:
- Multiple sclerosis: 20,241 reports
- High blood cholesterol: 11,039 reports
- Primary pulmonary hypertension: 5,307 reports
- High blood pressure: 3,116 reports
All the conditions that are associated with Skin blushing/flushing:
- Skin blushing/flushing (2,729 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on dupilumab (the active ingredients of Dupixent) and Dupixent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Naproxen and Biliary Tract Disorder - a second ago
- L-Tyrosine and Abdominal Pain Aggravated - 4 seconds ago
- Trimox and Dermatitis - 5 seconds ago
- Lidoderm and Multiple Sclerosis Relapse - 7 seconds ago
- Namenda vs. Evekeo - 8 seconds ago
- Differin and Chest Pain - 14 seconds ago
- Blood Creatinine Increased and drugs of ingredients of mupirocin - 16 seconds ago
- Risperidone and Menometrorrhagia - 18 seconds ago
- Paracetamol and Specific Gravity Urine Decreased - 35 seconds ago
- Glycopyrrolate and Depressive Symptom - 45 seconds ago